Envista (NVST) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this maker of dental products would post earnings of $0.27 per share when it actually produced earnings of $0.11, delivering a surprise of -59.26%.Over the last four quarters, th ...

The market expects Envista (NVST) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

BREA, Calif., Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the c ...

BREA, Calif., Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay. There will be no recording link available for this event. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by ...

Did you analyze how Envista (NVST) fared in its international operations for the quarter ending June 2024? Given the widespread global presence of this maker of dental products, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities. In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must ...

Envista Holdings Corporation (NVST) reported adjusted earnings per share (EPS) of 11 cents for secondquarter 2024, down 74.4% year over year. The bottom line missed the Zacks Consensus Estimate by 59.3%. The adjustments include a $1.15 billion non-cash charge related to the impairment of goodwill and intangible assets, charges and benefits related to the amortization of acquired intangible assets and restructuring costs, among others. The company's GAAP loss was $6.69 compared with the year-ago quarter's ea ...

Envista (NVST) reported $633.1 million in revenue for the quarter ended June 2024, representing a year-overyear decline of 4.4%. EPS of $0.11 for the same period compares to $0.43 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $647.99 million, representing a surprise of -2.30%. The company delivered an EPS surprise of -59.26%, with the consensus EPS estimate being $0.27. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Envista (NVST) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -59.26%. A quarter ago, it was expected that this maker of dental products would post earnings of $0.31 per share when it actually produced earnings of $0.26, delivering a surprise of -16.13%. Over the last four quarters, ...

Analysts on Wall Street project that Envista (NVST) will announce quarterly earnings of $0.27 per share in its forthcoming report, representing a decline of 37.2% year over year. Revenues are projected to reach $647.99 million, declining 2.2% from the same quarter last year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. ...

Eric Hammes joins Envista as Chief Financial Officer Stefan Nilsson joins Envista as President, Nobel Biocare Veronica Acurio joins Envista as President, Ormco Eric Hammes is appointed Chief Financial Officer effective August 8, 2024. He succeeds Stephen Keller who has served as Interim Principal Financial Officer since September 2023. Mr. Keller will return to his previous role leading investor relations. Mr. Hammes said, "I am thrilled to join Envista at this exciting time in the company's history. Envist ...